Related Experiment Video
Updated: Aug 16, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Character of the gastric and duodenal electrical activity after blocking of the adrenoreactive structures
Abstract:
Experiments are carried out on six dogs with chronically implanted electrodes in the gastric wall and in the duodenum. The electrical activity of the stomach (EGMG) and of the duodenum (EEG) is recorded. The myoelectrical complex of the stomach consists of four phases. The first phase records only slow potentials and lasts 40--60 min. The appearance of spike activity in the duodenum is always preceded by EGMG activation. Intravenous injection of the specific blocker of the alpha-adrenergic structures (phentolamine -- 1 mg/kg) leads to the appearance of spike activity in EGMG and EEG. 50--60 per cent of the slow waves being accompanied by spike potentials. At the same time the frequency of the slow potentials from EGMG is also decreased. Application of beta-adrenoblocker (propranolol -- 2 mg/kg) does not change subatantially EGMG and EEG. Simultaneous administration of alpha- and beta-adrenoblockers prolongs spiking time in the stomach and duodenum (spike potentials are recorded for 120--180 min, duration in the background 40--50 min). The influence of the interactions of cholinergic and adrenergic structures on the character of EGMG and EEG is discussed.
More Related Videos
07:29Real-time Analysis of Gut-brain Neural Communication: Cortex wide Calcium Dynamics in Response to Intestinal Glucose Stimulation
Published on: December 29, 2023
07:12Studying the Coding Profiles of Somatic Stimulation on Cardiac-locked Neuronal Responses in the Rat Spinal Dorsal Horn
Published on: May 23, 2025
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Blockers
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...